|
Hi Laurel,
I believe it is very important for all new members who come on the board to have all the updated facts. The protocol for early stage has changed. While no one wants to expose themselves to these drugs, often times because a tumor is small many newly dx. feel that offers some added protection. I just thought they should be armed to know that size is not the issue anymore. We hope that the day will soon arrive when we understand the complex biochemical signaling pathways involved and that tumors will be reviewed and treated based on their own genes. We still do not know why some have resistance to herceptin or a test to determine that. Knowledge is power...and at the very least women need to know everything they can so they can make the best treatment choices for themselves.
All Good Wishes,
Jean
__________________
Stage 1, Grade 1, 3/30/05
Lumpectomy 4/15/05 - 6MM IDC
Node Neg. (Sentinel node)
ER+ 90% / PR-, Her2+++ by FISH
Ki-67 40%
Arimidex 5/05
Radiation 32 trt, 5/30/05
Oncotype DX test 4/17/06, 31% high risk
TOPO 11 neg. 4/06
Stopped Arimidex 5/06
TCH 5/06, 6 treatments
Herceptin 5/06 - for 1 yr.
9/06 Completed chemo
Started Femara Sept. 2006
Last edited by Jean; 06-18-2009 at 09:31 PM..
|
Threaded Mode